COVID-19 Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020)

Food and Drug Administration (FDA)

This is a quick summary of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

April 09, 2020

An enforcement policy for sterilizers, disinfectant devices, and air purifiers was published in 2020 by the Food and Drug Administration (FDA).[1]

Due to the COVID-19 pandemic, it is necessary to maintain an adequate supply of sterilizers, disinfectant devices, and air purifiers to reduce the risk of viral exposure for patients and healthcare providers.

The FDA does not intend to object to the distribution and use of sterilizers, disinfectant devices, and air purifiers that do not already have FDA marketing authorization.

Modifications to these devices typically require premarket authorization by the FDA, but due to the pandemic and to ensure availability of equipment, the FDA does not intend to object to limited modifications.

The FDA recommends any modifications to sterilizers, disinfectant devices, and air purifiers be designed, evaluated, and validated in accordance with FDA-recognized standards.

If modifications are made, the FDA recommends that sterilizers, disinfectant devices, and air purifiers include labeling that helps users better understand the modifications.

For more Clinical Practice Guidelines, go to COVID-19 Clinical Guidelines.

For more information, go to Novel Coronavirus Resource Center and Coronavirus Disease 2019 (COVID-19).

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....